---
figid: PMC8444957__AGM2-4-221-g001
figtitle: Advances in research on pharmacotherapy of sarcopenia
organisms:
- Homo sapiens
- Mus musculus
- gut metagenome
- Sorghum bicolor
pmcid: PMC8444957
filename: AGM2-4-221-g001.jpg
figlink: /pmc/articles/PMC8444957/figure/agm212168-fig-0001/
number: F1
caption: Signaling of the pharmacotherapies of sarcopenia. By targeting multiple pathways,
  such as myostatin (MSTN), renin‐angiotensin system (RAS), androgen receptor (AR),
  activated protein kinase (AMPK) signaling, potential drugs rebalance protein synthesis
  and degradation, reshape the endocrine system, reduce oxidative stress and promote
  mitochondrial function, result in beneficial effects in muscle hypertrophy. Green
  and red arrows demonstrate promoting and inhibiting effects, respectively. Yellow
  arrows indicate the pathway of side effect. The indirect impacts are illustrated
  with dash lines.
papertitle: Advances in research on pharmacotherapy of sarcopenia.
reftext: Yang Feike, et al. Aging Med (Milton). 2021 Sep;4(3):221-233.
year: '2021'
doi: 10.1002/agm2.12168
journal_title: Aging Medicine
journal_nlm_ta: Aging Med (Milton)
publisher_name: John Wiley and Sons Inc.
keywords: aging | muscle wasting | pathogenesis | pharmacotherapy | sarcopenia | signaling
automl_pathway: 0.9362653
figid_alias: PMC8444957__F1
figtype: Figure
organisms_ner:
- Mus musculus
- Homo sapiens
redirect_from: /figures/PMC8444957__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8444957__AGM2-4-221-g001.html
  '@type': Dataset
  description: Signaling of the pharmacotherapies of sarcopenia. By targeting multiple
    pathways, such as myostatin (MSTN), renin‐angiotensin system (RAS), androgen receptor
    (AR), activated protein kinase (AMPK) signaling, potential drugs rebalance protein
    synthesis and degradation, reshape the endocrine system, reduce oxidative stress
    and promote mitochondrial function, result in beneficial effects in muscle hypertrophy.
    Green and red arrows demonstrate promoting and inhibiting effects, respectively.
    Yellow arrows indicate the pathway of side effect. The indirect impacts are illustrated
    with dash lines.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ras
  - Hras
  - Kras
  - Rem1
  - Ace
  - Agtrap
  - Mas1
  - Ar
  - Sarm1
  - Ang3
  - Angpt4
  - Angptl1
  - Ang6
  - Ang5
  - Angpt1
  - Ang
  - Tm7sf2
  - Ang2
  - Angpt2
  - Ang4
  - Ace2
  - Agt
  - Src
  - Cybb
  - Igf1
  - Pik3r1
  - Akt1
  - Mtor
  - Rps6kb1
  - Dpyd
  - Mstn
  - Acvr1
  - Fst
  - Ephb2
  - Mapk1
  - Acvr2a
  - Acvr1b
  - Fbxo32
  - Trim63
  - di
  - Mapk8
  - Smad2
  - Smad4
  - KRAS
  - HRAS
  - NRAS
  - ACE
  - AGTR1
  - AR
  - SARM1
  - VPS51
  - ANGPTL1
  - ANGPT4
  - ANGPTL3
  - ANGPT1
  - TM7SF2
  - ANGPT2
  - ACE2
  - PRRT2
  - PRKCA
  - PRKCB
  - PRKCD
  - PRKCE
  - PRKCG
  - PRKCH
  - PRKCI
  - PRKCQ
  - PRKCZ
  - PRKD3
  - SRC
  - FGR
  - FYN
  - YES1
  - CYBB
  - IGF1
  - IGF1R
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - AKT1
  - AKT2
  - AKT3
  - MTOR
  - RPS6KB1
  - PRKAA1
  - PRKAA2
  - PRKAB1
  - PRKAB2
  - PRKAG1
  - PRKAG2
  - PRKAG3
  - DPYD
  - FOXO1
  - FOXO3
  - FOXO4
  - FOXO6
  - MSTN
  - FST
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - EPHB2
  - ACVR2A
  - ACVR1
  - ACVR1B
  - FBXO32
  - TRIM63
  - SMAD2
  - SMAD4
---
